Retatrutide: The Next GLP-1 Drug Producing 28% Weight Loss — What Americans Need to Know
Eli Lilly’s retatrutide produced up to 28% weight loss — surpassing every existing drug and approaching surgical outcomes. A 40-year pharmacist explains how this next-generation triple hormone drug works, what makes it different from Ozempic, and when Americans can expect it.